Fig. 1From: Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin–angiotensin–aldosterone system (RAAS) inhibitors: a systematic reviewCell infection of SARS-CoV-2 and the role of renin-angiotensin-aldosterone system [17]Back to article page